North America was the largest region in the hematology drugs market in 2017, accounting for around 40% market share. This can be attributed to established healthcare market coupled with nationwide health insurance coverage in countries such as the USA and Canada. Western Europe was the second largest region accounting for around 20% market share. Asia Pacific was the third largest region accounting for around 18% market share.
Hematology Drugs Market Global Briefing 2018 provides strategists, marketers and senior management with the critical information they need to assess the global hematology drugs sector.
Hematology Drugs Market Global Briefing 2018 from the Business Research Company covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies for this market.
The market characteristics section of the report defines and explains the market.
The market size section gives the hematology drugs market revenues, covering both the historic growth of the market and forecasting the future.
Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
Market segmentations break down the key sub sectors which make up the market. The regional breakdowns section gives the size of the market geographically.
Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in the last three years are identified.
The trends and strategies section highlights the likely future developments in the hematology drugs market and suggests approaches.
Reasons To Purchase
- Fully updated for 2018.
• Identify growth segments and opportunities.
• Facilitate decision making on the basis of historic and forecast data and understand the drivers and restraints on the market.
• Develop strategies based on likely future developments.
• Gain a global perspective on the development of the market.
Markets Covered: Blood Products, Anemia And Other Blood Disorder Drugs.
Companies Mentioned: Novo Nordisk A/S, Shire Plc., Bayer AG, Daiichi Sankyo Company Limited, Biogen Inc., Pfizer Inc.
Geographic scope: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa
Time series: Five years historic and forecast.
Data: Market value in $ billions.
Data segmentations: Regional breakdowns, market share of competitors, key sub segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Table of Contents
Table of Contents
Hematology Drugs Market Characteristics 4
Hematology Drugs Market Historic Growth (2013-17) 6
Hematology Drugs Market Forecast Growth (2017-21) 7
Hematology Drugs Market Segmentation 8
Global Hematology Drugs Market, Split By Segments, 2017, $ Billion 8
Blood Products 8
Anemia And Other Blood Disorder Drugs 9
Global Hematology Drugs Market, Historic and Forecast, Split By Segments, 2013-2021 10
Hematology Drugs Market Geography Regional and Country Comparison 11
Global Hematology Drugs Market, Split By Regions, 2017 11
Global Hematology Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2013-2021 13
Global Hematology Drugs Market, Split By Country, 2017 15
Global Hematology Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2013-2021 17
Hematology Drugs Market Competitive Landscape 19
Novo Nordisk A/S 20
Shire Plc. 20
Bayer AG 20
Daiichi Sankyo Company, Limited 20
Biogen Inc. 20
Pfizer Inc. 20
Novo Nordisk 21
Shire Plc. 21
Bayer AG 22
Hematology Drugs Market Key Mergers And Acquisitions 23
Sumitomo Dainippon Pharma Co. Ltd. Acquired Tolero Pharmaceuticals 23
Novartis Acquired Selexys Pharmaceuticals Corporation And SelG1 Antibody 23
Miragen Therapeutics, Inc. Merged With Signal Genetics, Inc. 23
RXi Pharmaceuticals Acquired MirImmune Inc. 23
Sorrento Therapeutics, Inc., Merged With Yuhan Corporation 23
Hematology Drugs Market Trends And Strategies 24
Tranexamic Acid To Prevent Postpartum Hemorrhage 24
Increase In Product Approvals for Hemophilia 24
Gene Therapy For Treatment Of Sickle-Cell Disease 24
Genetically Engineered Drug For Von Willebrand Disease (VWD) 25
NAICS Definitions Of Industry Covered In This Report 26
Definition Of Market Covered In This Report 26
Research Methodology 27
Research Inquiries 28
The Business Research Company 28
List of Figures
Figure 1: Global Hematology Drugs Market, Historic Market Size, 2013-2017, $ Billion 6
Figure 2: Global Hematology Drugs Market, Forecast Market Size, 2017 – 2021, $ Billion 7
Figure 3: Global Hematology Drugs Market, Split By Segments, 2017, $ Billion 8
Figure 4: Global Hematology Drugs Market, Historic and Forecast, Split By Segment, 2013 – 2021 10
Figure 5: Global Hematology Drugs Market, Split By Region, 2017, $ Billion 11
Figure 6: Global Hematology Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2013-2021 13
Figure 7: Global Hematology Drugs Market, Split By Country, 2017, $ Billion 15
Figure 8: Global Hematology Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2013-2021 17
Figure 9: Global Hematology Drugs Market, Key Competitor Estimated Market Shares, 2017, Percentage (%) 1
The Business Research Company
47 Anchorage Point,
42 Cuba Street, Canary Wharf,
+44 207 1930 708